Our lung cancer panel of PD-L1-high cell lines included three squamous cell carcinomas without any known oncogenic driver mutations and one large cell carcinoma with a KRAS (Q61H) mutation (Table 1). This evidence concerns the gene KRAS and lung carcinoma.